Detalhe da pesquisa
1.
[Predictive PD-L1 immunohistochemistry for non-small cell lung cancer : Current state of the art and experiences of the first German harmonization study]. / Prädiktive PD-L1-Immunhistochemie beim nichtkleinzelligen Bronchialkarzinom : Aktueller Stand und Erfahrungen der ersten deutschen Harmonisierungsstudie.
Pathologe
; 37(6): 557-567, 2016 Nov.
Artigo
em Alemão
| MEDLINE | ID: mdl-27510417
2.
Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer-final results of the EUCROSS trial.
ESMO Open
; 9(2): 102237, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350336